Mechanisms of aluminium neurotoxicity in oxidative stress-induced ...
Mechanisms of aluminium neurotoxicity in oxidative stress-induced ... Mechanisms of aluminium neurotoxicity in oxidative stress-induced ...
REFERENCES Savory J., Herman M. M. and Ghribi O. (2006) Mechanisms of aluminum-induced 234 neurodegeneration in animals: Implications for Alzheimer's disease. J. Alzheimers Dis. 10, 135–144. Schaefer K., von Herrath D., Erley C. M. (1988) Treatment of uremic hyperphosphatemia–is there still a need for aluminum salts? Am. J. Nephrol. 8, 173–178. Schapira A. H. V. (1999) Science, medicine, and the future: Parkinson's disease. BMJ 318, 311– 314. Schapira A. H. (2008) Mitochondria in the aetiology and pathogenesis of Parkinson's disease. Lancet Neurol. 7, 97–109. Schapira A. H., Mann V. M., Cooper J. M., Krige D., Jenner P. J. and Marsden C. D. (1992) Mitochondrial function in Parkinson’s disease. The Royal Kings and Queens Parkinson’s Disease Research Group. Ann. Neurol. 32, S116–S124. Schipper H. M., Liberman A. and Stopa E. G. (1998) Neural heme oxygenase-1 expression in idiopathic Parkinson’s disease. Exp. Neurol. 150, 60–68. Schmidt W. J. and Kretschmer B. D. (1997) Behavioural pharmacology of glutamate receptors in the basal ganglia. Neurosci. Biobehav. Rev. 21, 381–392. Schoenberg B. S., Osuntokun B. O., Adeuja A. O., Bademosi O., Nottidge V., Anderson D. W. and Haerer A. F. (1988) Comparison of the prevalence of Parkinson’s disease in black populations in the rural United States and in rural Nigeria: door-to-door community studies. Neurology 38, 645–646. Schrag A., Dodel R., Spottke A., Bornschein B., Siebert U. and Quinn N. P. (2007) Rate of clinical progression in Parkinson’s disease. A prospective study. Mov. Disord. 22, 938–945. Schulz J. B. and Dichgans J. (1999) Molecular pathogenesis of movement disorders: are protein aggregates a common link in neuronal degeneration. Curr. Opin. Neurol. 12, 433–439.
REFERENCES Sedelis M., Hofele K., Auburger G. W., Morgan S., Huston J. P. and Schwarting R. K. (2000) MPTP susceptibility in the mouse: behavioral, neurochemical, and histological analysis of gender and strain differences. Behav. Genet. 30, 171–182. Sedman A. B., Klein G. L., Merritt R. J., Miller N. L., Weber K. O., Gill W. L., Anand H. and Alfrey A. C. (1985) Evidence of aluminum loading in infants receiving intravenous therapy. N. Engl. J. Med. 312, 1337–1343. Seidler A., Hellenbrand W., Robra B. P., Vieregge P., Nischan P., Joerg J., Oertel W. H., Ulm G. and Schneider E. (1996) Possible environmental, occupational, and other etiologic factors for Parkinson's disease: a case-control study in Germany. Neurology 46, 1275–1284. Sgado P., Alberi L., Gherbassi D., Galasso S. L., Ramakers G. M., Alavian K. N., Smidt M. P., Dyck R. H. and Simon H. H. (2006) Slow progressive degeneration of nigral dopaminergic neurons in postnatal Engrailed mutant mice. Proc. Natl. Acad. Sci. U. S. A. 103, 15242– 15247. Shafer T. J. and Mundy W. R. (1995) Effects of aluminum on neuronal signal transduction: mechanisms underlying disruption of phosphoinositide hydrolysis. Gen. Pharmac. 26, 889– 895. Shafer T. J., Mundy W. R. and Wilson H. A. (1993) Aluminum decreases muscarinic, adrenergic, and metabotropic receptor-stimulated phosphoinositide hydrolysis in hippocampal and cortical slices from rat brain. Brain Res. 629, 133–140. Sharma P. and Mishra K. P. (2006) Aluminum-induced maternal and developmental toxicity and oxidative stress in rat brain: response to combined administration of Tiron and glutathione. Reprod. Toxicol. 21, 313–321. Sherer T. B., Betarbet R., Kim J. H. and Greenamyre J. T. (2003) Selective microglial activation in the rat rotenone model of Parkinson’s disease. Neurosci. Lett. 341, 87–90. Shiba K., Arai T., Sato S., Kubo S. I., Ohba Y., Mizuno Y. and Hattori N. (2009) Parkin stabilizes PINK1 through direct interaction. Biochem. Biophys. Res. Commun. 383, 331–335. 235
- Page 208 and 209: REFERENCES 184 1,2,3,6-tetrahydropy
- Page 210 and 211: REFERENCES 186 compacta of the subs
- Page 212 and 213: REFERENCES Chung K. K., Dawson V. L
- Page 214 and 215: REFERENCES Davies K. J. (2001) Degr
- Page 216 and 217: REFERENCES Dhillon A. S., Tarbutton
- Page 218 and 219: REFERENCES Ekstrand M. I., Falkenbe
- Page 220 and 221: REFERENCES Fleming S. M., Delville
- Page 222 and 223: REFERENCES Ghribi O., Dewitt D. A.,
- Page 224 and 225: REFERENCES Good P. F., Olanow C. W.
- Page 226 and 227: REFERENCES Hamilton E. I., Miniski
- Page 228 and 229: REFERENCES Hirsch E. C., Brandel J.
- Page 230 and 231: REFERENCES Inden M., Kitamura Y., T
- Page 232 and 233: REFERENCES Johnson V. J. and Sharma
- Page 234 and 235: REFERENCES Kim W. G., Mohney R. P.,
- Page 236 and 237: REFERENCES Kuhn W., Winkel R., Woit
- Page 238 and 239: REFERENCES 214 K.D. and Polymeropou
- Page 240 and 241: REFERENCES Maraganore D. M., Lesnic
- Page 242 and 243: REFERENCES McCord J. M. and Fridovi
- Page 244 and 245: REFERENCES Miu A. C. and Benga O. (
- Page 246 and 247: REFERENCES Nair V. D., McNaught K.,
- Page 248 and 249: REFERENCES Onyango I. G. (2008) Mit
- Page 250 and 251: REFERENCES Perez F. A. and Palmiter
- Page 252 and 253: REFERENCES Przedborski S. and Goldm
- Page 254 and 255: REFERENCES Rifat S. L., Eastwood M.
- Page 256 and 257: REFERENCES Rymar V. V., Sasseville
- Page 260 and 261: REFERENCES Shimizu H., Mori T., Koy
- Page 262 and 263: REFERENCES 238 the generation of hy
- Page 264 and 265: REFERENCES Taylor G. A., Moore P. B
- Page 266 and 267: REFERENCES Um J. W., Stichel-Gunkel
- Page 268 and 269: REFERENCES Vila M. and Przedborski
- Page 270 and 271: REFERENCES Whitehead M. W., Farrar
- Page 272 and 273: REFERENCES Yokel R. A. (2002a) Alum
- Page 274: REFERENCES Zhou W., Zhu M., Wilson
REFERENCES<br />
Sedelis M., H<strong>of</strong>ele K., Auburger G. W., Morgan S., Huston J. P. and Schwart<strong>in</strong>g R. K. (2000)<br />
MPTP susceptibility <strong>in</strong> the mouse: behavioral, neurochemical, and histological analysis <strong>of</strong><br />
gender and stra<strong>in</strong> differences. Behav. Genet. 30, 171–182.<br />
Sedman A. B., Kle<strong>in</strong> G. L., Merritt R. J., Miller N. L., Weber K. O., Gill W. L., Anand H. and Alfrey<br />
A. C. (1985) Evidence <strong>of</strong> alum<strong>in</strong>um load<strong>in</strong>g <strong>in</strong> <strong>in</strong>fants receiv<strong>in</strong>g <strong>in</strong>travenous therapy. N.<br />
Engl. J. Med. 312, 1337–1343.<br />
Seidler A., Hellenbrand W., Robra B. P., Vieregge P., Nischan P., Joerg J., Oertel W. H., Ulm G.<br />
and Schneider E. (1996) Possible environmental, occupational, and other etiologic factors<br />
for Park<strong>in</strong>son's disease: a case-control study <strong>in</strong> Germany. Neurology 46, 1275–1284.<br />
Sgado P., Alberi L., Gherbassi D., Galasso S. L., Ramakers G. M., Alavian K. N., Smidt M. P., Dyck<br />
R. H. and Simon H. H. (2006) Slow progressive degeneration <strong>of</strong> nigral dopam<strong>in</strong>ergic<br />
neurons <strong>in</strong> postnatal Engrailed mutant mice. Proc. Natl. Acad. Sci. U. S. A. 103, 15242–<br />
15247.<br />
Shafer T. J. and Mundy W. R. (1995) Effects <strong>of</strong> alum<strong>in</strong>um on neuronal signal transduction:<br />
mechanisms underly<strong>in</strong>g disruption <strong>of</strong> phospho<strong>in</strong>ositide hydrolysis. Gen. Pharmac. 26, 889–<br />
895.<br />
Shafer T. J., Mundy W. R. and Wilson H. A. (1993) Alum<strong>in</strong>um decreases muscar<strong>in</strong>ic, adrenergic,<br />
and metabotropic receptor-stimulated phospho<strong>in</strong>ositide hydrolysis <strong>in</strong> hippocampal and<br />
cortical slices from rat bra<strong>in</strong>. Bra<strong>in</strong> Res. 629, 133–140.<br />
Sharma P. and Mishra K. P. (2006) Alum<strong>in</strong>um-<strong>in</strong>duced maternal and developmental toxicity<br />
and <strong>oxidative</strong> <strong>stress</strong> <strong>in</strong> rat bra<strong>in</strong>: response to comb<strong>in</strong>ed adm<strong>in</strong>istration <strong>of</strong> Tiron and<br />
glutathione. Reprod. Toxicol. 21, 313–321.<br />
Sherer T. B., Betarbet R., Kim J. H. and Greenamyre J. T. (2003) Selective microglial activation <strong>in</strong><br />
the rat rotenone model <strong>of</strong> Park<strong>in</strong>son’s disease. Neurosci. Lett. 341, 87–90.<br />
Shiba K., Arai T., Sato S., Kubo S. I., Ohba Y., Mizuno Y. and Hattori N. (2009) Park<strong>in</strong> stabilizes<br />
PINK1 through direct <strong>in</strong>teraction. Biochem. Biophys. Res. Commun. 383, 331–335.<br />
235
Change language